$0 (0.0%)
Industry, Sector & symbol
| Stock Exchange | OTC |
| CEO | Karim Mecklai |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Current Symbol | ELIXF |
| CUSIP | 28660W200 |
| CIK | None |
| Web | https://www.elixxer.ca |
| Phone | +1 416 847 1831 |
| Currency | USD |
| Employees | 0 |
| Country | CA |
Liquidity
| Debt-to-Equity Ratio | -0.98 |
| Payout Ratio | 0.00 |
| Current Ratio | 0.00 |
| Quick Ratio | 0.00 |
| Cash Ratio | 0.00 |
Sales & Book Value
| Annual Sales | $- |
| Price / Sales | 0.00 |
| Cash Flow | -0.06 |
| Price / Cash Flow | -46.58 |
| Price / Book | -0.05 |
Price Target and Rating
| Average Stock Price Forecast | $ |
| High Stock Price Forecast | $ |
| Low Stock Price Forecast | $ |
| Forecast Upside/Downside | % |
| Consensus Rating | Sell |
| Rating Score(0-5) | 2 |
| Research Coverage | 0 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | $-0.34 |
| Trailing P/E Ratio | -0.14 |
| PEG Ratio | -0.01 |
| P/E Growth | -0.01 |
| Net Income | $-3.87M |
| Net Margin | 0.00% |
| Pretax Margin | 0.00% |
| Return on Equity | 29.22% |
| Return on Assets | -364.36% |
Financials Score
| AltmanZ Score | -133.64 |
| Piotroski Score | 1.00 |
| Working Capital | -11.06M |
| Total Assets | 1.06M |
| Ebit | -665.38K |
| Market Cap | 33.06M |
| Total Liabilities | 11.11M |
About Elixxer Ltd. (OTC:ELIXF) Stock
Elixxer Ltd. operates as an investment company specifically focused on the cannabis industry. This firm strategically deploys capital into fully licensed businesses engaged in the cultivation, production, and sale of medicinal and specialized cannabis, as well as cannabis-derived products, predominantly for the pharmaceutical sector. Its investment reach extends across Canada, Australia, Italy, Jamaica, and Switzerland. Founded in 2004, the Montreal, Canada-based company adopted its current name, Elixxer Ltd., in August 2019, having previously been known as LGC Capital Ltd. ...
Elixxer Announces Adoption of Semi-Annual Reporting
2026-05-01 17:15:00
Toronto, Ontario--(Newsfile Corp. - May 1, 2026) - Elixxer Ltd. (TSXV: ELXR.H) ("Elixxer" or the "Company") announces its intention to adopt the policies outlined in the Semi-Annual Reporting ("SAR") Pilot Program utilizing the exemptions provided under Coordinated Blanket Order 51-933 Exemptions to Permit Semi-Annual Reporting for Certain Venture Issuers (the "Blanket Order").
Frequently Asked Questions
What is the current Elixxer Ltd. (ELIXF) stock price?
Elixxer Ltd.(OTC:ELIXF) stock price is $0.0335 in the last trading session. During the trading session, ELIXF stock reached the peak price of $0.0991 while $0.0013 was the lowest point it dropped to. The percentage change in ELIXF stock occurred in the recent session was 0.0% while the dollar amount for the price change in ELIXF stock was $0.
ELIXF's industry and sector of operation?
The OTC listed ELIXF is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.
Who are the executives of ELIXF?
Karim Mecklai
| Chief Executive Officer
Fiona Fitzmaurice
| Chief Financial Officer
Kym No
| Corporate Controller
Michael Kozub
| Corporate Secretary
Richard Widmann
| EVP of Commercial
How many employees does ELIXF have?
Number of ELIXF employees currently stands at 0. ELIXF operates from 100 Boulevard Rene- Levesque Ouest, Montreal, QC H5B 4N4, CA.
Link for ELIXF official website?
Official Website of ELIXF is: https://www.elixxer.ca
How do I contact ELIXF?
ELIXF could be contacted at phone #+1 416 847 1831 and can also be accessed through its website. ELIXF operates from 100 Boulevard Rene- Levesque Ouest, Montreal, QC H5B 4N4, CA.
How many shares of ELIXF are traded daily?
The average number of ELIXF shares traded daily for last 3 months was 595.65.
What is the market cap of ELIXF currently?
The market value of ELIXF currently stands at $23.35M with its latest stock price at $0.0335